Satoshi Arai
Innovative Research Institute, R&D Division, Morinaga Milk Industry Co., Ltd., 5-1-83, Higashihara, Zama 252-8583, Kanagawa, Japan
ORCID: 0000-0002-0700-6830- Papers in database
- 9
- Years active
- 2023 – 2025
- Health outcomes studied
- 6
Health Outcomes Studied
Papers (9)
- 2025Synbiotic combination of <i>Bifidobacterium longum</i> BB536 and lactulose improves the presenteeism of healthy adults associated with aromatic lactic acids - A single-arm, open-label study.10.1080/29933935.2025.2490092
- 2024Bifidobacterium breve M-16V regulates the autonomic nervous system via the intestinal environment: A double-blind, placebo-controlled study.10.1016/j.bbr.2023.114820
- 2024Effects of <i>Bifidobacterium longum</i> BB536 and <i>Bifidobacterium breve</i> MCC1274 on Body Composition in Normal and Overweight Adults in Randomized Placebo-Controlled Study.10.3390/nu16060815
- 2024The Impact of Fermented Milk Products Containing <i>Bifidobacterium longum</i> BB536 on the Gut Environment: A Randomized Double-Blind Placebo-Controlled Trial.10.3390/nu16213580
- 2024Immunomodulatory activity of heat-killed <i>Lacticaseibacillus paracasei</i>MCC1849 based on the activation of plasmacytoid dendritic cells in the peripheral blood of healthy adults.10.1002/fsn3.4009
- 2024Effects of Heat-Killed <i>Lacticaseibacillus paracasei</i> MCC1849 on Immune Parameters in Healthy Adults-A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.10.3390/nu16020216
- 2023Effects of Heat-Killed <i>Lacticaseibacillus paracasei</i> MCC1849 on the Maintenance of Physical Condition in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.10.3390/nu15153450
- 2023Early Probiotic Supplementation of Healthy Term Infants with Bifidobacterium longum subsp. infantis M-63 Is Safe and Leads to the Development of Bifidobacterium-Predominant Gut Microbiota: A Double-Blind, Placebo-Controlled Trial10.3390/nu15061402
- 2023The Potential Immunomodulatory Effect of Bifidobacterium longum subsp. longum BB536 on Healthy Adults through Plasmacytoid Dendritic Cell Activation in the Peripheral Blood10.3390/nu16010042